Advertisement
CI vs CVS
Which Stock Would AI Choose? Cigna (CI) vs. CVS Health (CVS) Stock Comparison
Key Takeaways
- Cigna (CI) operates primarily as a managed care and health services provider, while CVS Health (CVS) combines pharmacy retail, benefits management, and insurance through its integrated model.
- Both stocks have shown resilience in the healthcare sector amid broader market volatility, with performance influenced by regulatory developments and consumer health spending trends in recent weeks.
- CI has benefited from steady demand for employer-sponsored plans and specialty pharmacy services, contributing to relatively stable trading patterns.
- CVS faces ongoing pressures from reimbursement rates and competition in retail pharmacy but maintains scale advantages through its vast store network and PBM (Pharmacy Benefit Manager) operations.
- Relative momentum favors consistency in CI’s insurance-focused metrics, while CVS offers potential upside from cost synergies and digital health initiatives.
- Sector exposure to U.S. healthcare policy and inflation in medical costs remains a shared risk factor for both equities.
Introduction
Investors and traders seeking to compare healthcare equities often examine Cigna (CI) and CVS Health (CVS) due to their overlapping yet distinct positions in the U.S. healthcare ecosystem. CI focuses on insurance and health services, whereas CVS integrates pharmacy retail, benefits management, and insurance. This comparison appeals to those evaluating relative performance, sector exposure, and risk-adjusted positioning within a defensive industry. Market participants monitoring policy changes, enrollment trends, and operational efficiencies may find the analysis useful for portfolio construction or tactical allocation decisions.
CI Overview and Recent Performance
Cigna (CI) provides health insurance, pharmacy benefits, and related services to employers, governments, and individuals. In recent market activity, the stock has demonstrated steady behavior supported by consistent enrollment in commercial and Medicare segments. Sentiment has been shaped by favorable medical loss ratio trends and growth in specialty services. Broader healthcare spending patterns and cost-management initiatives have contributed to investor confidence, with the shares reflecting resilience relative to more cyclical sectors.
CVS Overview and Recent Performance
CVS Health (CVS) operates a diversified platform encompassing retail pharmacies, a large pharmacy benefit manager, and health insurance through Aetna. Recent performance has reflected challenges from reimbursement pressures and store traffic dynamics, offset by efforts to optimize its integrated model. Market activity shows sensitivity to consumer healthcare utilization and regulatory scrutiny of PBM practices. The company continues to pursue efficiency measures and expansion in health services to support longer-term positioning.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and risk parameters, yet only those demonstrating strong suitability for prevailing market conditions appear in the trending section. Available bots span a wide range of performance statistics, including win rates often between 55-75% and varying drawdown profiles depending on the strategy. All AI trading bots feature distinct trading styles, statistical track records, and ticker sets. Review the full selection on the Trending AI Robots page for detailed metrics and live performance data.
Head-to-Head Comparison
Cigna (CI) and CVS Health (CVS) differ markedly in business models: CI emphasizes insurance underwriting and health services, while CVS derives revenue from retail dispensing, PBM fees, and integrated insurance. Growth drivers for CI center on membership expansion and specialty drug management; CVS relies on pharmacy volume, cost synergies, and health services diversification. Recent momentum has tilted toward CI’s more predictable insurance metrics, whereas CVS contends with retail margin compression. Risk factors include policy changes for both, with CVS additionally exposed to pharmacy reimbursement variability. Sector exposure remains healthcare-centric, though CI offers purer insurance play and CVS provides retail and services breadth. Market sentiment reflects these trade-offs, with stability favoring CI and scale opportunities supporting CVS.
Tickeron AI Verdict
Based on observable factors such as trend consistency in insurance metrics, relative stability amid sector pressures, and positioning within defensive healthcare, Tickeron’s AI models currently assign a probabilistic edge to Cigna (CI) over CVS Health (CVS). This assessment weighs recent momentum patterns and catalyst visibility without implying certainty or future outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a StrongBuy and CVS is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 1 FA rating(s) are green whileCVS’s FA Score has 3 green FA rating(s).
- CI’s FA Score: 1 green, 4 red.
- CVS’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 3 TA indicator(s) are bullish while CVS’s TA Score has 3 bullish TA indicator(s).
- CI’s TA Score: 3 bullish, 6 bearish.
- CVS’s TA Score: 3 bullish, 5 bearish.
Price Growth
CI (@Managed Health Care) experienced а -3.63% price change this week, while CVS (@Managed Health Care) price change was -3.07% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -2.68%. For the same industry, the average monthly price growth was -9.13%, and the average quarterly price growth was +40.99%.
Reported Earning Dates
CI is expected to report earnings on Oct 29, 2026.
CVS is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Managed Health Care (-2.68% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CI | CVS | CI / CVS | |
| Capitalization | 73.7B | 133B | 55% |
| EBITDA | 12.8B | 11.1B | 115% |
| Gain YTD | 2.537 | 34.666 | 7% |
| P/E Ratio | 11.54 | 45.80 | 25% |
| Revenue | 281B | 408B | 69% |
| Total Cash | 7.17B | N/A | - |
| Total Debt | 31.9B | 78.3B | 41% |
CI | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 68 | 63 | |
SMR RATING 1..100 | 56 | 88 | |
PRICE GROWTH RATING 1..100 | 51 | 5 | |
P/E GROWTH RATING 1..100 | 75 | 6 | |
SEASONALITY SCORE 1..100 | 43 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (3) in the Drugstore Chains industry is in the same range as CI (4) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CI’s over the last 12 months.
CVS's Profit vs Risk Rating (63) in the Drugstore Chains industry is in the same range as CI (68) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CI’s over the last 12 months.
CI's SMR Rating (56) in the Managed Health Care industry is in the same range as CVS (88) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
CVS's Price Growth Rating (5) in the Drugstore Chains industry is somewhat better than the same rating for CI (51) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CI’s over the last 12 months.
CVS's P/E Growth Rating (6) in the Drugstore Chains industry is significantly better than the same rating for CI (75) in the Managed Health Care industry. This means that CVS’s stock grew significantly faster than CI’s over the last 12 months.
| CI | CVS | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 58% | 4 days ago 78% |
| Stochastic ODDS (%) | 4 days ago 65% | 4 days ago 63% |
| Momentum ODDS (%) | 4 days ago 52% | 4 days ago 60% |
| MACD ODDS (%) | 4 days ago 54% | 4 days ago 54% |
| TrendWeek ODDS (%) | 4 days ago 51% | 4 days ago 59% |
| TrendMonth ODDS (%) | 4 days ago 62% | 4 days ago 62% |
| Advances ODDS (%) | 7 days ago 63% | 14 days ago 67% |
| Declines ODDS (%) | 4 days ago 54% | 4 days ago 58% |
| BollingerBands ODDS (%) | 4 days ago 52% | 4 days ago 64% |
| Aroon ODDS (%) | N/A | 4 days ago 63% |
Advertisement
CI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.